BAC
Bank of America Corporation
BAC has the edge over ERIE overall, supported by stronger fundamentals and stronger modeled upside.
ERIE
Erie Indemnity Company
ERIE's outlook is improving, though it still trails on the overall score.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
ERIE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
ERIE's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like ERIE.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over ERIE in the historical PE scenario, which offers more potential upside but is not a forecast.
ERIE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 20x | $270 | — |
| Cheap | 27x | $201 | -26% |
| Fair | 35x | $266 | -1.4% |
| Current | 36x | $270 | — |
| Expensive | 43x | $324 | +20% |
Historical ranges are pointers, not guarantees.
ERIE's PE is 36x, but its earnings don't support one, so it isn't a reliable read right now.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over ERIE on the outlook, with more favorable revenue expectations.
ERIE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect ERIE's earnings to grow and its profitability to improve, with its revenue holding steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over ERIE on earnings, with more consistent year-over-year improvement.
ERIE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.23 | +76% |
| Q3 2026 | $7.51 | -39% |
| Q2 2026 | $10.98 | -8.2% |
| Q1 2026 | $10.87 | -7.5% |
| Q4 2025 | $10.66 | -7.1% |
| Q3 2025 | $12.37 | +16% |
| Q2 2025 | $11.96 | +18% |
| Q1 2025 | $11.75 | +27% |
| Q4 2024 | $11.48 | +35% |
ERIE's earnings per share have fallen from their peak: $7.51 over the past year, against $12.37 in late 2025.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over ERIE on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over ERIE on profitability, with a higher operating margin.
ERIE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +0.2% |
| Q2 2026 | $1.1B | +2.8% |
| Q1 2026 | $1B | +2.3% |
| Q4 2025 | $951.2M | +2.9% |
| Q3 2025 | $1.1B | +6.7% |
| Q2 2025 | $1.1B | +7% |
| Q1 2025 | $989.4M | +12% |
| Q4 2024 | $924.1M | +13% |
ERIE's revenue has grown year over year every quarter since late 2020: $1.1B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 19% | -0.3 points |
| Q2 2026 | 19% | -0.1 points |
| Q1 2026 | 16% | +1.1 points |
| Q4 2025 | 17% | -1.5 points |
| Q3 2025 | 20% | +1.7 points |
| Q2 2025 | 19% | -0.4 points |
| Q1 2025 | 15% | -0.5 points |
| Q4 2024 | 18% | +2.6 points |
ERIE's operating margin was 19% last quarter, about level with the same quarter a year ago, near the top of its range since 2019.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
ERIE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $185.4M | +0.5% |
| Q2 2026 | $173.4M | +10% |
| Q1 2026 | $54.5M | -38% |
| Q4 2025 | $140.8M | -4.1% |
| Q3 2025 | $184.4M | +7.6% |
| Q2 2025 | $157.3M | +52% |
| Q1 2025 | $88.4M | +37% |
| Q4 2024 | $146.8M | +15% |
ERIE has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has 7.2B diluted shares, down 5.3% from a year ago, with $25.6B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
ERIE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.7% | -390K shares |
| 1 year | 0% | -8.3K shares |
| 3 years | -0.7% | -383K shares |
| 5 years | -10% | -6.1M shares |
| Available history | -10% | -6.1M shares |
ERIE has the edge over BAC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
ERIE hasn't bought back shares in the past year.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
ERIE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | -0.4x | Net Cash |
ERIE has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
ERIE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.0 | Neutral |
| Stochastic | 74.4 | Neutral |
ERIE's weekly RSI is 59 (neutral) and its Stochastic is 74 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over ERIE on valuation relative to its sector.
ERIE PE vs Financial Services Sector
| Metric | ERIE | Sector median | Relative |
|---|---|---|---|
| PE | 36x | 13x | 176% above |
| PE % | 52 | 63 | 11 pts below |
ERIE is trading at 36x earnings, a 176% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
ERIE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $246.0 | 9.8% above |
| 20 week MA | $247.1 | 9.3% above |
| 50 week MA | $251.3 | 7.4% above |
| 100 week MA | $307.6 | 12% below |
| 200 week MA | $321.0 | 16% below |
ERIE has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
ERIE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $166.4 | $243.3 | +46% |
| 2021 | $243.3 | $190.2 | -22% |
| 2022 | $190.2 | $276.3 | +45% |
| 2023 | $276.3 | $334.9 | +21% |
| 2024 | $334.9 | $419.3 | +25% |
| 2025 | $419.3 | $282.4 | -33% |
| 2026 YTD | $282.4 | $270.0 | -4.4% |
ERIE has the edge over BAC on returns for 2026, with the stronger performance.